ipilimumab,nivolumab,Dabrafenib,Trametinib
bms,novartis
['melanoma']
dreamseq (ea6134) results in pts w advanced melanoma, being presented at #asco22 by michael atkins, md. 20% survival improvement. 
Biomarker-driven medical research involving adults who have or are at risk of developing cancer